Dimerix (DXB) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock DXB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Dimerix launches key trial in Japan as recruitment kicks offMay 30 at 1:33 AM | msn.comFirst site open for Dimerix kidney disease trial in Japan, triggers milestone paymentMay 30 at 1:33 AM | msn.comDimerix Limited Announces New Securities Quotation on ASXMay 28 at 11:53 PM | tipranks.comDimerix Limited Issues New Securities to Strengthen Market PositionMay 27 at 12:21 AM | tipranks.comLunch Wrap: ASX wobbles on bond fears but Bitcoin looks spicy on its ‘Pizza Day’May 22, 2025 | msn.comClosing Bell: Gold stocks rally but ASX slumps 0.45pcMay 22, 2025 | msn.comHealth Check: ‘Forgotten’ drug maker AFT Pharma aims high with revenueMay 21, 2025 | msn.comDimerix Limited Announces Quotation of New Securities on ASXMay 21, 2025 | tipranks.comDimerix Advances Phase 3 Kidney Trial with Positive Safety ReviewMay 21, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXMay 19, 2025 | tipranks.comDimerix Limited Sees Increase in Substantial ShareholdingMay 19, 2025 | tipranks.comDimerix to Present Key Updates at Melbourne Investor BriefingMay 19, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXMay 13, 2025 | tipranks.comDr Boreham’s Crucible: The wheels keep turning for Dimerix and its kidney drug candidateMay 12, 2025 | msn.comDimerix Limited Announces Quotation of New Securities on ASXMay 11, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXMay 8, 2025 | tipranks.comDimerix banks upfront US$30m payment in US pharma licensing deal for kidney drugMay 6, 2025 | msn.comHealth Check: Biotechs recover as peace descends on the FDA – for nowMay 5, 2025 | msn.comDimerix and Amicus to commercialise DMX-200 in USMay 2, 2025 | msn.comGuess which ASX All Ords stock is rocketing 58% on big US newsMay 1, 2025 | msn.comDimerix inks lucrative US licensing deal for phase III drug candidateMay 1, 2025 | msn.comHealth Check: Dimerix shares soar as the company hooks the billion-dollar big one in the USMay 1, 2025 | msn.comDimerix Limited Announces Quotation of New Securities on ASXMay 1, 2025 | tipranks.comHealth Check: We’re a goer says Aroa, with US tariffs unlikely to be a ‘major headwind’April 29, 2025 | msn.comDimerix Limited Issues New Securities to Bolster Market PositionApril 28, 2025 | tipranks.comDimerix charts path to full marketing approval for DMX-200April 27, 2025 | msn.comHealth Check: Telix licks its wounds after FDA knocks back brain cancer diagnosticApril 27, 2025 | msn.comDimerix Limited Issues New Securities to Boost Market PositionApril 22, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXApril 16, 2025 | tipranks.comDimerix Showcases Phase 3 Kidney Disease Asset at ASX CEO ConnectApril 14, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXApril 10, 2025 | tipranks.comDimerix Updates Securities Trading Policy Amidst Clinical AdvancementsApril 7, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXApril 3, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXApril 1, 2025 | tipranks.comDimerix to Present at HealthInvest Summit 2025 Highlighting FSGS Clinical Trial ProgressApril 1, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXMarch 27, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXMarch 26, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXMarch 19, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXMarch 14, 2025 | tipranks.comDimerix to Present at Euroz Hartleys Conference, Highlighting Progress in Kidney Disease TreatmentMarch 12, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXMarch 5, 2025 | tipranks.comDimerix banks initial $3.2m payment in Japanese pharma licensing deal for kidney drugMarch 4, 2025 | msn.comDimerix posts modest gain as first Japanese payment for DMX-200 landsMarch 4, 2025 | msn.comDimerix Limited Announces Quotation of New Securities on ASXMarch 2, 2025 | tipranks.comPetra Capital Reaffirms Their Buy Rating on Dimerix Limited (DXB)February 23, 2025 | markets.businessinsider.comDimerix Limited Announces Quotation of New SecuritiesFebruary 17, 2025 | tipranks.comDimerix Limited Issues New Securities to Enhance Market PositionFebruary 11, 2025 | tipranks.comASX healthcare leaders wear many hats in interconnected sectorFebruary 11, 2025 | msn.comDimerix Limited Announces Application for Quotation of New SecuritiesFebruary 10, 2025 | tipranks.comDimerix Corrects Director Interest NoticeFebruary 4, 2025 | tipranks.com Get Dimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for DXB and its competitors with MarketBeat's FREE daily newsletter. Email Address DXB Media Mentions By Week DXB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DXB News Sentiment▼0.040.88▲Average Medical News Sentiment DXB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DXB Articles This Week▼41▲DXB Articles Average Week Get Dimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for DXB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BIO News ZBIO News PRTC News OXB News FARN News NGENF News FRX News CYBN News BVXP News 4BB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:DXB) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dimerix Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dimerix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DXB Stock Free DXB Stock Alerts